Stay updated on Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.

Latest updates to the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedThe Record History page now shows revision v3.6.5 instead of v3.6.4, signaling that a new page version was deployed. This reflects a minor update to the page's underlying version rather than changes to trial data or user actions.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe revision label on the page changed from v3.6.3 to v3.6.4, indicating a new site build reflected in the history. This is a site-level update and does not alter trial information displayed on the page.SummaryDifference0.1%

- Check22 days agoChange DetectedVersion 56 adds the Contacts/Locations and Study Status sections, signaling updated recruitment status and site details for the study. The history also shows removal of an entry dated 2026-07-06 from the record.SummaryDifference0.3%

- Check29 days agoChange DetectedNew history entries on 2026-07-01 and 2026-07-06 introduce or update the Contacts/Locations and Study Status sections; a deletion on 2026-06-05 removes an earlier item, reflecting updates to how the study's contact details and current status are recorded.SummaryDifference0.3%

- Check36 days agoChange DetectedA new revision tag, Revision: v3.6.3, was added and the previous tag, Revision: v3.6.2, was removed from the history page, indicating a small software version update to the record.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page shows Revision: v3.6.2, replacing the previous v3.6.0. This indicates an update to the platform version used to render the study history record.SummaryDifference0.1%

Stay in the know with updates to Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.